Trials / Completed
CompletedNCT04190004
Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- National Institute of Mental Health and Neuro Sciences, India · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The study investigates the effect of 40IU of intranasal vasopressin on cooperative behavior in patients with schizophrenia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vasopressins | 40 International units of vasopressin or placebo will be given intra-nasally. The order of the administration will be counterbalanced |
| DRUG | Placebo | 40 International units of vasopressin or placebo will be given intra-nasally. The order of the administration will be counterbalanced |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-11-30
- Completion
- 2018-11-30
- First posted
- 2019-12-09
- Last updated
- 2019-12-09
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04190004. Inclusion in this directory is not an endorsement.